CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors
Pilot Study of Feasibility and Safety of Personalized Autologous CD8+ T Cell Therapy Plus Anti-PD1 Antibody in Advanced Solid Malignancies
Sponsor: M.D. Anderson Cancer Center
Terminated
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
Other terminated trials from M.D. Anderson Cancer Center
Other Colorectal Adenocarcinoma trials with similar outcome
A PHASE1 clinical study on Colorectal Adenocarcinoma and Metastatic Cholangiocarcinoma, this trial is terminated or withdrawn. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 19 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
19 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
▶ Show 14 earlier versions
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE1
-
Dec 2019 — Aug 2020 [monthly]
Active Not Recruiting PHASE1
Status: Enrolling By Invitation → Active Not Recruiting
-
Oct 2019 — Dec 2019 [monthly]
Enrolling By Invitation PHASE1
Status: Recruiting → Enrolling By Invitation
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Not Yet Recruiting PHASE1
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE1
-
Dec 2018 — May 2019 [monthly]
Not Yet Recruiting PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE1
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE1
-
May 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .